איקסמפרה 15 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

IXABEPILONE 15 MG

Verfügbar ab:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC-Code:

L01DC04

Darreichungsform:

POWDER FOR CONCENTRATE FOR INFUSION

Verabreichungsweg:

I.V

Hergestellt von:

CORDEN PHARMA LATINA S.P.A., ITALY

Therapiegruppe:

IXABEPILONE

Anwendungsgebiete:

Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.

Berechtigungsdatum:

2012-01-01